bioRxiv Science⌕ Search

Biology subjects

Quillen, S.

Publications and source records attributed to Quillen, S..

4 recordsLinked to original sources

Regional Gene Expression in the Retina, Optic Nerve Head, and Optic Nerve of Mice with Experimental Glaucoma and Optic Nerve Crush

A major risk factor for glaucomatous optic neuropathy is the level of intraocular pressure (IOP), which can lead to retinal ganglion cell axon injury and cell death. The optic nerve has a rostral unmyelinated portion at the optic nerve head followed by a caudal myelinated region. The unmyelinated region is differentially susceptible to IOP-induced damage in rodent models and in human glaucoma. While several studies have analyzed gene expression changes in the mouse optic nerve following optic nerve injury, few were designed to consider the regional gene expression differences that exist between these distinct areas. We performed bulk RNA-sequencing on the retina and on separately micro-dissected unmyelinated and myelinated optic nerve regions from naive C57BL/6 mice, mice after optic nerve crush, and mice with microbead-induced experimental glaucoma (total = 36). Gene expression patterns in the naive unmyelinated optic nerve showed significant enrichment of the Wnt, Hippo, PI3K-Akt, and transforming growth factor {beta} pathways, as well as extracellular matrix-receptor and cell membrane signaling pathways, compared to the myelinated optic nerve and retina. Gene expression changes induced by both injuries were more extensive in the myelinated optic nerve than the unmyelinated region, and greater after nerve crush than glaucoma. Changes three and fourteen days after injury largely subsided by six weeks. Gene markers of reactive astrocytes did not consistently differ between injury states. Overall, the transcriptomic phenotype of the mouse unmyelinated optic nerve was significantly different from immediately adjacent tissues, likely dominated by expression in astrocytes, whose junctional complexes are inherently important in responding to IOP elevation.

molecular biology↗

Internal limiting membrane disruption facilitates engraftment of transplanted human stem cell derived retinal ganglion cells

Optic neuropathies cause irreversible vision loss as retinal ganglion cells (RGCs) die. Transplantation of pluripotent stem cell (PSC)-derived RGCs offers one potential therapeutic avenue to restore vision in patients suffering from optic neuropathy if the donor neurons survive long-term in the recipient eye and develop synaptic connections within the retinal inner plexiform layer (IPL) and subcortical visual centers (1). Thus far, attempts at intravitreal RGC transplantation have been hampered by sequestration on the epiretinal surface without engraftment into the retinal parenchyma. In mouse retinal explant cultures, enzymatic digestion of the retinal internal limiting membrane (ILM) promotes migration of transplanted RGCs into the recipient retina (2). Herein, we examined donor RGC survival and engraftment in living, immunosuppressed mice, rats, and rhesus macaques and in post-mortem human retinal explant cultures. Using 3 separate human PSC lines and 3 independent methods of ILM disruption, we demonstrate that the ILM is a barrier to the retinal engraftment of intravitreally delivered human PSC-derived RGCs. ILM disruption is associated with greater donor RGC survival over 2-8 weeks and enables migration of donor neuronal somas into the endogenous RGC layer where cells elaborate dendrites into the IPL and extend axons that follow the course of the endogenous retinal nerve fiber layer into the optic nerve head. Critically, ILM disruption enables donor RGCs to synaptically integrate into IPL circuits, conferring light responsivity. These findings have important implications for enabling neuronal replacement therapies to restore vision in patients with optic neuropathy. SIGNIFICANCE STATEMENTRetinal ganglion cell (RGC) replacement and optic nerve regeneration through transplantation of stem cell-derived RGCs holds potential for restoring vision lost to optic neuropathies. Here we demonstrate that intravitreally transplanted human RGCs laminate the epiretinal surface without projecting neurites into the retinal parenchyma. However, enzymatic, developmental and surgical disruption of the internal limiting membrane not only improves graft survival, but also enables structural and functional engraftment, with dendrites that stratify the inner plexiform layer, axons that grow into the optic nerve head, and acquired responsivity to light. These observations identify a translatable approach to enable transplantation-based RGC replacement for the treatment of optic neuropathy.

neuroscience↗

The Role of Aquaporin-4 in Optic Nerve Head Astrocytes in Experimental Glaucoma

PurposeTo study aquaporin channel expression in astrocytes of the mouse optic nerve (ON) and the response to IOP elevation in mice lacking aquaporin 4 (AQP4 null). MethodsC57BL/6 (B6) and AQP4 null mice were exposed to bead-induced IOP elevation for 3 days (3D-IOP), 1 and 6 weeks. Mouse ocular tissue sections were immunolabeled against aquaporins 1(AQP1), 4(AQP4), and 9(AQP9). Ocular tissue was imaged to identify normal AQP distribution, ON changes, and axon loss after IOP elevation. Ultrastructure examination, cell proliferation, gene expression & transport block was also analyzed. ResultsB6 mice presented abundant AQP4 in Muller cells, astrocytes of retina and myelinated ON (MON), but minimal expression in prelaminar and unmyelinated ON (UON). MON of AQP4 nulls had smaller ON area, smaller axon diameter, higher axon density, and larger proportionate axon area than B6 (all p[≤]0.05). Bead-injection led to comparable 3D-IOP elevation (p=0.42) and axonal transport blockade in both strains. In B6, AQP4 distribution was unchanged after 3D-IOP. At baseline, AQP1 and AQP9 were present in retina, but not in UON and this was unaffected after IOP elevation in both strains. In 3D-IOP mice, ON astrocytes and microglia proliferated, more in B6 than AQP4 null. After 6 week IOP elevation, axon loss occurred equally in the two mouse types (24.6%, AQP4 null vs. 23.3%, B6). ConclusionLack of AQP4 was neither protective nor detrimental to the effects of IOP elevation. The minimal presence of AQP4 in UON may be a vital aspect of the regionally specific phenotype of astrocytes in the mouse optic nerve head.

molecular biology↗

Structural engraftment and topographic spacing of transplanted human stem cell-derived retinal ganglion cells

Retinal ganglion cell (RGC) replacement and optic nerve regeneration hold potential for restoring vision lost to optic neuropathy. Following transplantation, RGCs must integrate into the neuroretinal circuitry in order to receive afferent visual signals for processing and transmission to central targets. To date, the efficiency of RGC retinal integration following transplantation has been limited. We sought to characterize spontaneous interactions between transplanted human embryonic stem cell-derived RGCs and the recipient mature mammalian retina, and to identify and overcome barriers to the structural integration of transplanted neurons. Using an in vitro model system, following transplantation directly onto the inner surface of organotypic mouse retinal explants, human RGC somas form compact clusters and extend bundled neurites that remain superficial to the neural retinal tissue, hindering any potential for afferent synaptogenesis. To enhance integration, we explored methods to increase the cellular permeability of the internal limiting membrane (ILM). Digestion of extracellular matrix components using proteolytic enzymes was titrated to achieve disruption of the ILM while minimizing retinal toxicity and preserving endogenous retinal glial reactivity. Such ILM disruption is associated with dispersion rather than clustering of transplanted RGC bodies and neurites, and with a marked increase in transplanted RGC neurite extension into retinal parenchyma. The ILM appears to be a barrier to afferent retinal connectivity by transplanted RGCs and its circumvention may be necessary for successful functional RGC replacement through transplantation.

neuroscience↗